Lisa Bowers advises executives of both large and small biotech companies on corporate strategy, commercial strategy, leadership and management, board management, and overall job performance, and is currently an Executive in Residence at the UVA Licensing and Ventures Group. She was formerly the Chief Commercial Officer of Day One, and, prior to that role, was the CEO and founder of Rhia Ventures, a social venture investment organization focused on reproductive health. She has had an extensive career at Genentech/Roche, where she held P&L accountability for Genentech’s $400M+ cystic fibrosis business, and was the head of the North American supply chain region, accountable for $20B+ of medicine across the United States and Canada. Lisa has been a board observer for Cadence Health (a private biotech company), as well as a member of the board for Planned Parenthood Mar Monte, the largest affiliate in the country, and DICE Therapeutics, a public biotech company. She earned an English degree from Yale University and a Master of Health Services Administration from the University of Michigan School of Public Health.
